Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Yurika YamauchiIssei SaekiTakahiro YamasakiMaho EgusaNatsuko NishiyamaTsuyoshi FujiokaDaiki KawamotoTatsuro NishimuraNorikazu TanabeTakashi OonoToshihiko MatsumotoTsuyoshi IshikawaYoshio MarumotoSatoshi MatsukumaYoshitaro ShindoYukio TokumitsuSota YoshimineJunichi MurakamiToshiki TanakaSotai KimuraYoshinobu HoshiiKimikazu HamanoKazuhiko SakamotoTaro TakamiPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
To our best knowledge, this report is the first case to present HCV-related HCC followed by PHA and to show that Atezo/Bev therapy is beneficial for PHA.